Hepatitis C Direct-Acting Antivirals (DAAs)
Preferred regimens based on treatment guidelines from the American Association for the Study of Liver Diseases. Available at hcvguidelines.org. Medications listed in alphabetical order
| BRAND NAME | GENERIC (COMMON) NAME |
MANUFACTURER | GENOTYPE | COPAY CARD | PATIENT ASSISTANCE PROGRAM | GENERIC AVAILABLE |
|---|---|---|---|---|---|---|
| Epclusa | sofosbuvir/velpatasvir (SOF/VEL) |
Gilead authorized generic: Asegua Therapeutics LLC |
1 2 3 4 5 6 | 4* | 4 | 4* |
| Harvoni | sofosbuvir/ledipasvir (SOF/LDV) |
Gilead authorized generic: Asegua Therapeutics LLC |
1 4 5 6 | 4* | 4 | 4* |
| Mavyret | glecaprevir/pibrentasvir (GLE/PIB) |
AbbVie | 1 2 3 4 5 6 | 4 | 4 | 8 |
| Vosevi | sofosbuvir/velpatasvir/ voxilaprevir (SOF/VEL/VOX) |
Gilead | 1 2 3 4 5 6 | 4 | 4 | 8 |
| Zepatier | grazoprevir/elbasvir (GZR/EBR) |
Merck | 1 4 | 8 | 4 | 8 |